Indazole macrocycle polymorphs
GEAP202617019APending Publication Date: 2026-09-25BLOSSOMHILL THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- GEAP202617019P0
- Authority / Receiving Office
- GE · GE
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-11-26
- Filing Date
- 2024-12-06
- Publication Date
- 2026-09-25
Abstract
Abstract The present invention relates to polymorphs of (7E)-16-ethyl-8,12,14-trimethyl-2,11,12,14-tetrahydro-8H-3,5-ethenotripyrazolo[3,4-f:3',4'-j:4',3'-n][1,4]oxazacyclopentadecin-13(10H)-one, which can be used in mammals to treat diseases such as cancer. The present invention also relates to compositions containing such polymorphs and methods of using such compositions in the treatment of diseases such as cancer, in mammals, especially humans. 1
Need to check novelty before this filing date? Find Prior Art